Insider Stock Trading History of Alafi Moshe


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Alafi Moshe since year 2005. The trader's CIK number is 1008890. At the time of this reporting, Alafi Moshe is the 10% Owner of Intra-cellular Therapies, Inc. . (stock ticker symbol NONE). See this page for all insider trading activities at Intra-cellular Therapies, Inc. .

Note that in the past ALAFI MOSHE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Alafi Moshe since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 ITCI Intra-cellular Therapies, Inc. Buy 258,065 15.50 4,000,007
2016-12-06 ITCI Intra-cellular Therapies, Inc. Buy 44,174 16.33 721,449
2016-12-07 ITCI Intra-cellular Therapies, Inc. Buy 20,826 16.14 336,048
2016-11-14 ITCI Intra-cellular Therapies, Inc. Buy 34,000 14.50 492,966
2014-12-01 ITCI Intra-cellular Therapies, Inc. Buy 1,422 14.75 20,974
2014-11-28 ITCI Intra-cellular Therapies, Inc. Buy 35,000 14.75 516,250
2014-11-19 ITCI Intra-cellular Therapies, Inc. Buy 1,034 14.25 14,734
2014-11-14 ITCI Intra-cellular Therapies, Inc. Buy 133 15.07 2,004
2014-11-18 ITCI Intra-cellular Therapies, Inc. Buy 3,531 14.23 50,246
2014-11-11 ITCI Intra-cellular Therapies, Inc. Buy 5,000 15.55 77,750
2014-11-12 ITCI Intra-cellular Therapies, Inc. Buy 5,000 15.23 76,150
2014-11-13 ITCI Intra-cellular Therapies, Inc. Buy 2,200 15.12 33,264
2014-06-19 ITCI Intra-cellular Therapies, Inc. Sale 15,742 6.35 100,008
2007-03-15 STXS Stereotaxis, Inc. Buy 10,000 10.89 108,900
2005-12-06 STXS Stereotaxis, Inc. Buy 32,102 7.12 228,694

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alafi Moshe (10% Owner of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.